Adoptive cell therapy across cancer diagnoses

ABSTRACT: Primary objectives: The main objective is to determine the feasibility and safety of adoptive cell therapy in combination with checkpoint inhibition across different metastatic solid cancers. Primary endpoints: Toxicity: Registration of all AEs and unexpected events in relation to the treatment will be done in accordance with the common terminology criteria for adverse events (CTCAE) criteria as described in appendix 3.

DISEASE(S): Hepatic Cancer Metastatic,Pharyngeal Cancer Metastatic,Gallbladder Cancer Metastatic,Bone Cancer Metastatic,Biliary Cancer Metastatic,Tubular Breast Cancer Metastatic,Esophageal Cancer Metastatic,Tongue Cancer Metastatic,Jejunum Cancer Metastatic,Duodenal Cancer Metastatic,Lung Cancer Metastatic,Pituitary Cancer Metastatic,Colorectal Cancer Metastatic,Anal Cancer Metastatic,Rectosigmoid Cancer Metastatic,Urethral Cancer Metastatic,Renal Pelvis And Ureter Transitional Cell Cancer Metastatic,Vaginal Cancer Metastatic,Thymic Cancer Metastatic,Prostatic Cancer Metastatic,Vulval Cancer Metastatic,Small Cell Lung Cancer Metastatic,Laryngeal Cancer Metastatic,Oesophageal Cancer Metastatic,Sinus Cancer Metastatic,Tonsil Cancer Metastatic,Ovarian Epithelial Cancer Metastatic,Oral Cavity Cancer Metastatic,Nasopharyngeal Cancer Metastatic,Ureter Cancer Metastatic,Otic Cancer Metastatic,Thyroid Cancer Metastatic,Renal Cancer Metastatic,Ocular Cancer Metastatic,Large Cell Lung Cancer Metastatic,Cervix Cancer Metastatic,Testicular Germ Cell Cancer Metastatic,Colon Cancer Metastatic,Head And Neck Cancer Metastatic,Testicular Cancer Metastatic,Adrenal Gland Cancer Metastatic,Gastrointestinal Cancer Metastatic,Renal Pelvis And Ureteric Cancer Metastatic Transitional Cell,Breast Cancer Metastatic,Ureteric Cancer Metastatic,Pancreatic Cancer Metastatic,Germ Cell Cancer Metastatic,Prostate Cancer Metastatic,Ovarian Cancer Metastatic,Jejunal Cancer Metastatic,Skin Cancer Metastatic,Patients With Metastatic Solid Cancers In Stages Iii Or Iv Regardless Of Diagnosis.,Urethra Cancer Metastatic,Endometrial Cancer Metastatic,Non-small Cell Lung Cancer Metastatic,Rectal Cancer Metastatic,Fallopian Tube Cancer Metastatic

PROVIDER: 2537065 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR